Parkinson's drugs in development could work for nearly all patients. Research in human brain tissue and rodents found the mechanism the drugs target to be present in all patients, not just the 3% they were designed for.

See the source article by following the link below:
Parkinson's drugs in development could work for nearly all patients. Research in human brain tissue and rodents found the mechanism the drugs target to be present in all patients, not just the 3% they were designed for.